← back to search

Raymond R. Townsend

Newcastle University · US
Area of research
Cardiology and Cardiovascular Medicine · Nephrology
Research interest
Research interests include Blood Pressure and Hypertension Studies, Cardiovascular Health and Disease Prevention, Chronic Kidney Disease and Diabetes, and Dialysis and Renal Disease Management.
h-index
95
citations
52,164
works
819
NIH funding
primary concept
Medicine
email

Recent publications

Long-Term Safety and Efficacy of Renal Denervation: 24-Month Results From the SPYRAL HTN-ON MED Trial
Circulation Cardiovascular Interventions 2025cited by 9position: middledoi
Impact of Antihypertensive Medication Changes After Renal Denervation Among Different Patient Groups: SPYRAL HTN-ON MED
Hypertension 2024cited by 29position: firstdoi
Progression of Coronary Artery Calcification and Risk of Clinical Events in CKD: The Chronic Renal Insufficiency Cohort Study
American Journal of Kidney Diseases 2024cited by 15position: middledoi
Metabolites Associated With Uremic Symptoms in Patients With CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study
American Journal of Kidney Diseases 2024cited by 12position: middledoi
Safety and Efficacy of Renal Denervation in Patients Taking Antihypertensive Medications
Journal of the American College of Cardiology 2023cited by 108position: middledoi
SCAI Position Statement on Renal Denervation for Hypertension: Patient Selection, Operator Competence, Training and Techniques, and Organizational Recommendations
Journal of the Society for Cardiovascular Angiography & Interventions 2023cited by 35position: middledoi
Fibroblast Growth Factor 23 and Risk of Heart Failure Subtype: The CRIC (Chronic Renal Insufficiency Cohort) Study
Kidney Medicine 2023cited by 17position: middledoi
Effect of Intensive Blood Pressure Control on Kidney Outcomes
Clinical Journal of the American Society of Nephrology 2023cited by 15position: middledoi
The association between changes in echocardiography and risk of heart failure hospitalizations and death in adults with chronic kidney disease
Scientific Reports 2023cited by 4position: middledoi
Long-term efficacy and safety of renal denervation in the presence of antihypertensive drugs (SPYRAL HTN-ON MED): a randomised, sham-controlled trial
The Lancet 2022cited by 278position: middledoi
Long-term outcomes after catheter-based renal artery denervation for resistant hypertension: final follow-up of the randomised SYMPLICITY HTN-3 Trial
The Lancet 2022cited by 173position: middledoi
Arterial Stiffness and Diabetes Risk in Framingham Heart Study and UK Biobank
Circulation Research 2022cited by 74position: middledoi
Metabolite profiling of CKD progression in the chronic renal insufficiency cohort study
JCI Insight 2022cited by 55position: middledoi
Long-term reduction in morning and nighttime blood pressure after renal denervation: 36-month results from SPYRAL HTN-ON MED trial
Hypertension Research 2022cited by 51position: middledoi
Association of Chronic Kidney Disease With Risk of Intracerebral Hemorrhage
JAMA Neurology 2022cited by 47position: middledoi
Treatment Adherence in CKD and Support From Health care Providers: A Qualitative Study
Kidney Medicine 2022cited by 25position: middledoi
Hypertension urgencies in the SPYRAL HTN-OFF MED Pivotal trial
Clinical Research in Cardiology 2022cited by 10position: middledoi
Changes in Plasma Renin Activity After Renal Artery Sympathetic Denervation
Journal of the American College of Cardiology 2021cited by 108position: middledoi
Sex Differences in Cardiovascular Outcomes in CKD: Findings From the CRIC Study
American Journal of Kidney Diseases 2021cited by 58position: middledoi
Effect of Heart Rate on the Outcome of Renal Denervation in Patients With Uncontrolled Hypertension
Journal of the American College of Cardiology 2021cited by 53position: middledoi
Renal denervation in hypertension patients: Proceedings from an expert consensus roundtable cosponsored by <scp>SCAI</scp> and <scp>NKF</scp>
Catheterization and Cardiovascular Interventions 2021cited by 40position: middledoi
Upper Reference Limits for High-Sensitivity Cardiac Troponin T and N-Terminal Fragment of the Prohormone Brain Natriuretic Peptide in Patients With CKD
American Journal of Kidney Diseases 2021cited by 37position: middledoi
Iron status, fibroblast growth factor 23 and cardiovascular and kidney outcomes in chronic kidney disease
Kidney International 2021cited by 31position: middledoi
Ten-Year Risk-Prediction Equations for Incident Heart Failure Hospitalizations in Chronic Kidney Disease: Findings from the Chronic Renal Insufficiency Cohort Study and the Multi-Ethnic Study of Atherosclerosis
Journal of Cardiac Failure 2021cited by 22position: middledoi
Time-Updated Changes in Estimated GFR and Proteinuria and Major Adverse Cardiac Events: Findings from the Chronic Renal Insufficiency Cohort (CRIC) Study
American Journal of Kidney Diseases 2021cited by 20position: middledoi
Vitamin K status, all-cause mortality, and cardiovascular disease in adults with chronic kidney disease: the Chronic Renal Insufficiency Cohort
American Journal of Clinical Nutrition 2021cited by 19position: middledoi
Antihypertensive Class and Cardiovascular Outcomes in Patients With HIV and Hypertension
Hypertension 2021cited by 16position: middledoi
Association Between Kidney Clearance of Secretory Solutes and Cardiovascular Events: The Chronic Renal Insufficiency Cohort (CRIC) Study
American Journal of Kidney Diseases 2021cited by 16position: lastdoi
Prediction of Incident Atrial Fibrillation in Chronic Kidney Disease: The Chronic Renal Insufficiency Cohort Study
Clinical Journal of the American Society of Nephrology 2021cited by 16position: middledoi
Hospitalization Trajectories and Risks of ESKD and Death in Individuals With CKD
Kidney International Reports 2021cited by 13position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Harold I. Feldman · University of Pennsylvania73 papers (2012–2023)James P. Lash · University of Illinois Chicago68 papers (2012–2024)Mahboob Rahman · University School65 papers (2012–2023)Jiang He · Medical Research Council60 papers (2012–2022)Lawrence J. Appel · Johns Hopkins University Applied Physics Laboratory58 papers (2012–2023)Alan S. Go · Kaiser Permanente57 papers (2012–2023)John W. Kusek · National Institute of Diabetes and Digestive and Kidney Diseases47 papers (2012–2020)Dawei Xie · Capital Medical University33 papers (2012–2020)Panduranga S. Rao · University of Illinois Chicago32 papers (2018–2023)Akinlolu Ojo · University of Kansas Medical Center30 papers (2012–2020)Jing Chen · Tulane University27 papers (2012–2021)Chi‐yuan Hsu · Kaiser Permanente27 papers (2012–2021)Amanda H. Anderson · Tulane University23 papers (2014–2023)Nisha Bansal · University of Washington20 papers (2014–2023)Myles Wolf · Duke University20 papers (2012–2023)Rajat Deo · Penn Center for AIDS Research19 papers (2013–2021)David E. Kandzari · Santa Rosa Junior College19 papers (2012–2025)Ana C. Ricardo · Illinois College19 papers (2013–2021)James Sondheimer · Tulane University18 papers (2014–2023)Debbie L. Cohen · University of Pennsylvania15 papers (2013–2023)